The move provides the opportunity to conduct essential post-marketing surveillance

The trial will see around 300 people given the vaccine plus a booster shot up to four weeks […]

The ‘landmark’ decision invalidates Regeneron’s patent claims covering its genetically modified mice

The drug targets all solid tumours with the NTRK gene fusions

Updated Date: Wed, 17 Jun 2020 00:00:00 EDT

Updated Date: Wed, 17 Jun 2020 00:00:00 EDT

Updated Date: Wed, 17 Jun 2020 00:00:00 EDT

Updated Date: Wed, 17 Jun 2020 00:00:00 EDT

Updated Date: Wed, 17 Jun 2020 00:00:00 EDT

Merck treads on Sanofi, Regeneron’s turf with Keytruda’s latest skin cancer OK chelfand Wed, 06/24/2020 – 16:43